Recent Updates
Recently added Catalysts
TECH Positive Sentiment

BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th...

Wednesday, March 6, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bio-Techne Corporation (NASDAQ: TECH) announced that CEO Kim Kelderman will present at the Barclays 26th Annual Global Healthcare Conference on March 13, 2024. The event is aimed at showcasing the company's developments in the healthcare sector. Interested parties can access a live webcast of the presentation via the Investor Relations website.
Price reaction · baseline $73.4 (2024-03-05 close) · hit after-hours · clean, no other TECH news in the window
day 0 close · peak
+1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • CEO Kim Kelderman will present at a prestigious healthcare conference.
  • The presentation provides an opportunity for increased visibility.
  • A live webcast will allow broader audience access.

Full Press Release Details

MINNEAPOLIS , March 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced that Kim Kelderman , President and Chief Executive Officer, will present at the Barclays 26 th Annual Global Healthcare Conference on Wednesday, March 13, 2024 , at 8:30 a.m. EDT . A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar .
About Bio-Techne Corporation (NASDAQ: TECH )
Contact: David Clair, Vice President, Investor Relations & Corporate Development
[email protected]
612-656-4416

Frequently Asked Questions

When will Kim Kelderman present at the Barclays Conference?

Kim Kelderman will present on March 13, 2024, at 8:30 a.m. EDT.

How can I access the live webcast of the presentation?

The live webcast can be accessed via Bio-Techne's Investor Relations website.

Who is the contact for investor relations at Bio-Techne?

David Clair is the Vice President of Investor Relations at Bio-Techne.

What is the stock symbol for Bio-Techne Corporation?

Bio-Techne Corporation is listed under the stock symbol NASDAQ: TECH.

ShareAdd on Google
Tags: TECH Viatris Investor Conferences Healthcare Bio-Techne healthcare conference Kim Kelderman Barclays NASDAQ
Last updated: Mar 6, 2024

Biotech snapshot

Cash runway
$210M liquidity · $0M/mo burn
Low dilution risk